SlideShare uma empresa Scribd logo
1 de 34
Dr. A. R. M. Saifuddin Ekram
         MBBS, FCPS, FACP, PhD, FRCP
        Professor(CC)and Head
       Department of Medicine
      Rajshahi Medical College
                      Rajshahi
The patient usually has several monitors

attached to various parts of his or her body
for real-time evaluation of medical stability.
The intensivist will make periodic assessments

of the patient's cardiac status, breathing rate,
urinary output, and blood levels for nutritional
and hormonal problems that may arise and
require urgent attention or treatment.
Ref: Davidson's Principles & Practice of Medicine-20th Edition
Infections a hydra headed threat
   Critical care patients are at risk for
    developing endogenous and exogenous
    infections.

   The compromised patient with his health at
    its low is subjected to extra risk of
    infection, which can be transmitted from his
    caregiver or his visitors.
   Patients admitted with symptoms prior to
    hospitalization are considered to have
    community-acquired infections, and
   Those who develop infection more than 48
    hours following admission are considered to
    have           hospital-acquired,        or
    nosocomial, infections.
   Patients hospitalized in ICUs are 5 to 10
    times more likely to acquire nosocomial
    infections than other hospital patients.
   Infections that are of great concern to the
    critical care physician either because of a
    high     mortality     rate,     diagnostic
    challenge,           frequency           of
    occurrence, contagiousness, or acquisition
    of antimicrobial resistance are discussed
    here.
◦ Sepsis
◦ Community-acquired pneumonia
◦ Urosepsis
◦ Infective endocarditis
◦ Necrotizing soft tissue infections
◦ Intra-abdominal infections
 Nosocomial pneumonia
 Urinary catheter–associated infections
 Intravenous catheter–associated infections
 Clostridium difficile–associated diarrhea
 Haematogenously disseminated candidiasis
 Infections in special hosts
 Antimicrobial resistance in the ICU
 Botulism
 Tetanus
   Wide spectrum of clinical findings ranging from
    fever, hypothermia, tachycardia, and tachypnea to
    profound shock and multiple-organ-system failure.
   Severe or complicated sepsis: lactic acidosis, acute
    respiratory distress syndrome (ARDS), acute renal
    failure,    disseminated        intravascular  coagulation
    (DIC), shock, CNS dysfunction, or hepatobiliary disease.
   May present with altered mental status, unexplained
    hyperventilation, or tachycardia alone.
   Often an identifiable site of infection.
    Predisposing risk factors for infection: organ system
    failure, bed rest, invasive procedures, any antibiotic
    use, immunocompromised state.
   Patients present with cough, fever, and occasionally
    pleuritic chest pain.
   Chest x-ray shows pulmonary infiltrates.
   Most common cause of community-acquired
    pneumonia is Streptococcus pneumoniae.
   The patient may be asymptomatic.
   Flank or abdominal pain.
   Pyuria and white blood cell casts.
   Positive urine culture.
   Clinical presentation varies depending on infecting
    organism.
    Patients with S. aureus infective endocarditis typically
    present with a short prodrome and a sepsis syndrome.
   Clues to the diagnosis of sub-acute infective
    endocarditis include a new regurgitant murmur, Roth
    spots, Osler nodes, Janeway lesions, splinter
    hemorrhages, hematuria, and splenomegaly.
    Blood cultures are needed for diagnosis.
   Patients complain of pain out of proportion to
    physical findings.
    Essential to differentiate a necrotizing soft tissue
    infection from a simple cellulitis.
    Metabolic acidosis, renal insufficiency, and other
    signs of organ dysfunction may be present.
   Symptoms may be nonspecific, with patients
    reporting vague abdominal pain, anorexia, and fever.
    Abdominal examination may reveal absent or
    diminished bowel sounds, with peritoneal signs.
    Laboratory findings are nonspecific in patients with
    intra-abdominal sepsis.
    Fever, tachypnea, tachycardia, and abnormal
    breath sounds.
    Risk     factors   include   altered   mental
    status, lung disease, endotracheal tube, or
    tracheostomy.
    Change in volume or appearance of sputum.
    Infiltrates or other changes on chest x-ray.
    Hypoxemia or worsening arterial blood
    gases.
    Although       the       patient      may      be
    asymptomatic, suprapubic tenderness suggests
    lower tract infection; fever and flank pain suggest
    upper tract infection.

   Pyuria and white blood cell casts.

   Positive urine culture.
    Exit-site                             infection:
    erythema, tenderness, induration, and exudate at
    cutaneous exit site.

   Tunnel infection: induration, erythema, tenderness
    at least 1 cm deep to the skin exit site and without
    purulent drainage through the exit site.

    Catheter sepsis: fever, tachypnea, and tachycardia
    with positive blood cultures and no other site of
    infection identified.
   Watery diarrhea and low-grade fever.

   Previous or current treatment with antibiotics—but
    may occur as long as 6 weeks after antibiotic has
    been stopped.

   Presence of C. difficile toxin in stool.

   Sigmoidoscopy may reveal white or yellow plaques
    of pseudomembranous colitis.
    Fever despite broad-spectrum antibacterial
    therapy and negative bacterial blood cultures.

   Possible skin manifestations.

    Consider in neutropenic hosts and patients with
    long term vascular access.
   Many patients have underlying diseases that render them
    susceptible to specific pathogens. Included among these are
            Patients with neutropenia,
            Organ transplant recipients,
            Diabetics,
            Asplenic individuals,
            Patients on chronic corticosteroid therapy, and
            HIV-infected patients.
   Knowledge of an underlying condition may lead a physician to
    modify or broaden empirical antibiotic therapy when such a
    patient is admitted to the ICU with infection or suspected
    infection.
   The choice of antimicrobial agents to be used in
    established or strongly suspected bacterial or other
    infections must be based on an assessment of what
    organisms are most likely to be involved.

   Initial empirical therapy should be dictated, when
    possible, by results of Gram-stained smears of properly
    collected specimens such as sputum, urine, aspirated
    purulent         material,        or        body        fluids
    (eg,     blood,      cerebrospinal       fluid,   peritoneal
    fluid, synovial fluid, pleural fluid, or pericardial fluid).
   Specific resistance problems encountered in the ICU
    include
    ◦ vancomycin-resistant enterococci,
    ◦ methicillin-resistant S. aureus,
    ◦ glycopeptideinsensitiveS. aureus,
    ◦ gram-negative bacilli with extendedspectrumβ-
      lactamases,
    ◦ gram-negative bacilli that produce group 1 β-
      lactamases, and
    ◦ Acinetobacter baumanii.
   The evaluation of new fever in the ICU setting
    involves consideration of diagnoses much different
    from those encountered in patients in a community
    setting.

   Many noninfectious causes of fever must be
    considered and excluded in order to avoid missing
    important diagnoses and perhaps administering
    antimicrobial agents unnecessarily.
    Nausea, vomiting, dysphagia, diplopia, dilated and fixed
    pupils.
    Sudden weakness in a previously healthy person.
    Cranial nerves affected first (except I and II), followed
    by descending symmetric paralysis or weakness.
    Autonomic nervous system involvement: paralytic
    ileus, gastric dilation, urinary retention, and orthostatic
    hypotension.
    Absence of sensory or mental status changes.
    Botulism toxin isolated from serum, stool, or other
    body fluids.
   Generalized weakness or stiffness, with trismus
    (“lockjaw”) and severe generalized spasms.

   Opisthotonos and abdominal rigidity.

    Respiratory
    failure, tachycardia, hypertension,    fever,   and
    diaphoresis may be present.
   There should be monitoring of the infection pattern and
    the bacteria monitored in order to take the necessary
    steps to treat infection, prevent resistance development
    and preventing hospital acquired cross infection.

   Essential components of an infection-control program in
    the critical care environment are the structural design of
    the        critical     care     unit       and       the
    surveillance, prevention, and control of infection
    functions.
   Management strategies include employee infection
    control and education.

   Knowledge and education are the most important
    management tools in the control of infection in the
    critical care environment.
   There are eight infection control indicators in hospitals
    in critical care setting.
   The indicator set focuses on:
               surgical wound infections,
               postoperative pneumonia,
               use of urinary catheterization,
               ventilator-associated pneumonia,
               primary bloodstream infection,
               endometritis,
               adequacy of surveillance, and
               employee measles immunization.
   Critical care unit staff members may be involved in
    using indicator rates.

   Following the trend rates should suggest
    organizational systems and processes of care in
    critical care settings that may warrant further
    examination and improvement.
Infection in critical care

Mais conteúdo relacionado

Mais procurados

Nosocomial infections
Nosocomial infectionsNosocomial infections
Nosocomial infectionsHamidRahman14
 
Hiv and oppurtunistic infections
Hiv and oppurtunistic infectionsHiv and oppurtunistic infections
Hiv and oppurtunistic infectionsme2432 j
 
Severe acute respiratory syndrome
Severe acute respiratory syndrome Severe acute respiratory syndrome
Severe acute respiratory syndrome Shivangi sharma
 
مكافحة العدوي .... Infection Control
مكافحة العدوي .... Infection Controlمكافحة العدوي .... Infection Control
مكافحة العدوي .... Infection ControlAhmed Gemy
 
MERS CoV MOH Guidelines update 2015
MERS CoV MOH Guidelines update 2015MERS CoV MOH Guidelines update 2015
MERS CoV MOH Guidelines update 2015Mostafa Mahmoud
 
Epidemiological Surveillance.pptx
Epidemiological Surveillance.pptxEpidemiological Surveillance.pptx
Epidemiological Surveillance.pptxosmanconteh4
 
Community acquired pneumonia
Community acquired pneumoniaCommunity acquired pneumonia
Community acquired pneumoniaDrBakunda
 
INFECTION CONTROL PROGRAMME IN HEALTH CARE FACCILITY
 INFECTION CONTROL PROGRAMME IN HEALTH CARE FACCILITY INFECTION CONTROL PROGRAMME IN HEALTH CARE FACCILITY
INFECTION CONTROL PROGRAMME IN HEALTH CARE FACCILITYTauseef Jawaid
 

Mais procurados (20)

Rsv final
Rsv finalRsv final
Rsv final
 
Nosocomial infections
Nosocomial infectionsNosocomial infections
Nosocomial infections
 
Hiv and oppurtunistic infections
Hiv and oppurtunistic infectionsHiv and oppurtunistic infections
Hiv and oppurtunistic infections
 
32321.ppt
32321.ppt32321.ppt
32321.ppt
 
Hospital acquired infection
Hospital acquired infectionHospital acquired infection
Hospital acquired infection
 
Severe acute respiratory syndrome
Severe acute respiratory syndrome Severe acute respiratory syndrome
Severe acute respiratory syndrome
 
مكافحة العدوي .... Infection Control
مكافحة العدوي .... Infection Controlمكافحة العدوي .... Infection Control
مكافحة العدوي .... Infection Control
 
ARDS.pptx
ARDS.pptxARDS.pptx
ARDS.pptx
 
Covid 19 rajni sharma
Covid 19 rajni sharmaCovid 19 rajni sharma
Covid 19 rajni sharma
 
Vaccinating the elderly
Vaccinating the elderlyVaccinating the elderly
Vaccinating the elderly
 
Severe Acute Respiratory Syndrome
Severe Acute Respiratory SyndromeSevere Acute Respiratory Syndrome
Severe Acute Respiratory Syndrome
 
MERS CoV MOH Guidelines update 2015
MERS CoV MOH Guidelines update 2015MERS CoV MOH Guidelines update 2015
MERS CoV MOH Guidelines update 2015
 
INTENSIVE CARE UNIT (ICU) ASSOCIATED INFECTIONS Dr.T.V.Rao MD
INTENSIVE CARE UNIT (ICU)  ASSOCIATED INFECTIONS Dr.T.V.Rao MDINTENSIVE CARE UNIT (ICU)  ASSOCIATED INFECTIONS Dr.T.V.Rao MD
INTENSIVE CARE UNIT (ICU) ASSOCIATED INFECTIONS Dr.T.V.Rao MD
 
Epidemiological Surveillance.pptx
Epidemiological Surveillance.pptxEpidemiological Surveillance.pptx
Epidemiological Surveillance.pptx
 
Community acquired pneumonia
Community acquired pneumoniaCommunity acquired pneumonia
Community acquired pneumonia
 
INFECTION CONTROL PROGRAMME IN HEALTH CARE FACCILITY
 INFECTION CONTROL PROGRAMME IN HEALTH CARE FACCILITY INFECTION CONTROL PROGRAMME IN HEALTH CARE FACCILITY
INFECTION CONTROL PROGRAMME IN HEALTH CARE FACCILITY
 
Corona virus
Corona virusCorona virus
Corona virus
 
Ventilator Associated Pneumonia
Ventilator Associated PneumoniaVentilator Associated Pneumonia
Ventilator Associated Pneumonia
 
Chickenpox
ChickenpoxChickenpox
Chickenpox
 
Pneumonia by Dr. Sookun Rajeev Kumar
Pneumonia by Dr. Sookun Rajeev KumarPneumonia by Dr. Sookun Rajeev Kumar
Pneumonia by Dr. Sookun Rajeev Kumar
 

Destaque

Infectious diseases ( description of rickettsiosis )
Infectious diseases ( description of rickettsiosis )Infectious diseases ( description of rickettsiosis )
Infectious diseases ( description of rickettsiosis )MWIZERWA JEAN-LUC
 
Quaic intensive-care-unit-empirical-anti-treatment-guidelines
Quaic intensive-care-unit-empirical-anti-treatment-guidelinesQuaic intensive-care-unit-empirical-anti-treatment-guidelines
Quaic intensive-care-unit-empirical-anti-treatment-guidelinesisakakinada
 
Treating Infectious Illness in the ICU
Treating Infectious Illness in the ICUTreating Infectious Illness in the ICU
Treating Infectious Illness in the ICUAndrew Ferguson
 
Icu infection and its medical management by Dr. Aniket Geete
Icu infection and its medical management by Dr. Aniket GeeteIcu infection and its medical management by Dr. Aniket Geete
Icu infection and its medical management by Dr. Aniket GeeteAniket Geete
 
Infection control in icu
Infection control in icuInfection control in icu
Infection control in icuAtef Salama
 
Infection control in the ICU
Infection control in the ICUInfection control in the ICU
Infection control in the ICUJ MA
 
Infection control in icu setting
Infection control in icu setting  Infection control in icu setting
Infection control in icu setting MEEQAT HOSPITAL
 
Rickettsial infections
Rickettsial infectionsRickettsial infections
Rickettsial infectionsSingaram_Paed
 
leptospirosis
leptospirosisleptospirosis
leptospirosisIrene Ngu
 

Destaque (20)

Infectious diseases ( description of rickettsiosis )
Infectious diseases ( description of rickettsiosis )Infectious diseases ( description of rickettsiosis )
Infectious diseases ( description of rickettsiosis )
 
Quaic intensive-care-unit-empirical-anti-treatment-guidelines
Quaic intensive-care-unit-empirical-anti-treatment-guidelinesQuaic intensive-care-unit-empirical-anti-treatment-guidelines
Quaic intensive-care-unit-empirical-anti-treatment-guidelines
 
Treating Infectious Illness in the ICU
Treating Infectious Illness in the ICUTreating Infectious Illness in the ICU
Treating Infectious Illness in the ICU
 
Icu infection and its medical management by Dr. Aniket Geete
Icu infection and its medical management by Dr. Aniket GeeteIcu infection and its medical management by Dr. Aniket Geete
Icu infection and its medical management by Dr. Aniket Geete
 
Infection control in icu
Infection control in icuInfection control in icu
Infection control in icu
 
Infection control in the ICU
Infection control in the ICUInfection control in the ICU
Infection control in the ICU
 
ICU NOSOCOMAIL INFECTION AND INFECTION CONTROL
ICU NOSOCOMAIL INFECTION AND INFECTION CONTROL ICU NOSOCOMAIL INFECTION AND INFECTION CONTROL
ICU NOSOCOMAIL INFECTION AND INFECTION CONTROL
 
Leptospirosis 2015
Leptospirosis 2015Leptospirosis 2015
Leptospirosis 2015
 
Infection control in icu setting
Infection control in icu setting  Infection control in icu setting
Infection control in icu setting
 
Rickettsiosis
RickettsiosisRickettsiosis
Rickettsiosis
 
Rickettsial infections
Rickettsial infectionsRickettsial infections
Rickettsial infections
 
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
 
leptospirosis
leptospirosisleptospirosis
leptospirosis
 
Tetanus
TetanusTetanus
Tetanus
 
Leptospirosis
Leptospirosis Leptospirosis
Leptospirosis
 
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
 
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
 
Rickettsias
RickettsiasRickettsias
Rickettsias
 
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
 
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
 

Semelhante a Infection in critical care

19. presenting problems in infectious diseases
19. presenting problems in infectious diseases19. presenting problems in infectious diseases
19. presenting problems in infectious diseasesAhmad Hamadi
 
HAIs final.pptx
HAIs final.pptxHAIs final.pptx
HAIs final.pptxanjalatchi
 
13038030 surgical-infections
13038030 surgical-infections13038030 surgical-infections
13038030 surgical-infectionsTsega Tilahun
 
Therapies for Blood Disorders.pptx
Therapies for Blood Disorders.pptxTherapies for Blood Disorders.pptx
Therapies for Blood Disorders.pptxhayatalakoum1
 
ventilator-associated pneumonia.ppt
ventilator-associated pneumonia.pptventilator-associated pneumonia.ppt
ventilator-associated pneumonia.pptssuser0622881
 
Concepts of infection control main - copy
Concepts of infection control main - copyConcepts of infection control main - copy
Concepts of infection control main - copyAmos Allan Subba
 
Concepts of IC.ppt
Concepts of IC.pptConcepts of IC.ppt
Concepts of IC.pptssuser88477e
 
Update management of CAP
Update management of CAPUpdate management of CAP
Update management of CAPSaher Farghly
 
Meningitis nursing, medical managements
Meningitis nursing, medical managementsMeningitis nursing, medical managements
Meningitis nursing, medical managementsReynel Dan
 
Lecture 9. hospital aquired infection
Lecture 9. hospital aquired infectionLecture 9. hospital aquired infection
Lecture 9. hospital aquired infectionVasyl Sorokhan
 
Management of infections in immunocompromised patients
Management of infections in immunocompromised patientsManagement of infections in immunocompromised patients
Management of infections in immunocompromised patientsSujay Iyer
 
Purulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissuePurulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissueMOHAMMAD NOUR AL SAEED
 
Immunopatologi Sepsis
Immunopatologi SepsisImmunopatologi Sepsis
Immunopatologi SepsisDoroteaNina1
 
Nosocomial infections
Nosocomial infectionsNosocomial infections
Nosocomial infectionsJasmine John
 

Semelhante a Infection in critical care (20)

Infectious diseases
Infectious diseasesInfectious diseases
Infectious diseases
 
19. presenting problems in infectious diseases
19. presenting problems in infectious diseases19. presenting problems in infectious diseases
19. presenting problems in infectious diseases
 
Antibiotics in icu
Antibiotics in icuAntibiotics in icu
Antibiotics in icu
 
HAIs final.pptx
HAIs final.pptxHAIs final.pptx
HAIs final.pptx
 
13038030 surgical-infections
13038030 surgical-infections13038030 surgical-infections
13038030 surgical-infections
 
Therapies for Blood Disorders.pptx
Therapies for Blood Disorders.pptxTherapies for Blood Disorders.pptx
Therapies for Blood Disorders.pptx
 
Pcp
PcpPcp
Pcp
 
Typhoid Fever
Typhoid FeverTyphoid Fever
Typhoid Fever
 
ventilator-associated pneumonia.ppt
ventilator-associated pneumonia.pptventilator-associated pneumonia.ppt
ventilator-associated pneumonia.ppt
 
Concepts of infection control main - copy
Concepts of infection control main - copyConcepts of infection control main - copy
Concepts of infection control main - copy
 
Concepts of IC.ppt
Concepts of IC.pptConcepts of IC.ppt
Concepts of IC.ppt
 
Update management of CAP
Update management of CAPUpdate management of CAP
Update management of CAP
 
Shock
ShockShock
Shock
 
Meningitis nursing, medical managements
Meningitis nursing, medical managementsMeningitis nursing, medical managements
Meningitis nursing, medical managements
 
Lecture 9. hospital aquired infection
Lecture 9. hospital aquired infectionLecture 9. hospital aquired infection
Lecture 9. hospital aquired infection
 
Management of infections in immunocompromised patients
Management of infections in immunocompromised patientsManagement of infections in immunocompromised patients
Management of infections in immunocompromised patients
 
Purulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissuePurulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissue
 
Immunopatologi Sepsis
Immunopatologi SepsisImmunopatologi Sepsis
Immunopatologi Sepsis
 
Nosocomial infections
Nosocomial infectionsNosocomial infections
Nosocomial infections
 
Meningitis
MeningitisMeningitis
Meningitis
 

Infection in critical care

  • 1. Dr. A. R. M. Saifuddin Ekram MBBS, FCPS, FACP, PhD, FRCP Professor(CC)and Head Department of Medicine Rajshahi Medical College Rajshahi
  • 2.
  • 3.
  • 4. The patient usually has several monitors attached to various parts of his or her body for real-time evaluation of medical stability.
  • 5. The intensivist will make periodic assessments of the patient's cardiac status, breathing rate, urinary output, and blood levels for nutritional and hormonal problems that may arise and require urgent attention or treatment.
  • 6. Ref: Davidson's Principles & Practice of Medicine-20th Edition
  • 7. Infections a hydra headed threat
  • 8. Critical care patients are at risk for developing endogenous and exogenous infections.  The compromised patient with his health at its low is subjected to extra risk of infection, which can be transmitted from his caregiver or his visitors.
  • 9. Patients admitted with symptoms prior to hospitalization are considered to have community-acquired infections, and  Those who develop infection more than 48 hours following admission are considered to have hospital-acquired, or nosocomial, infections.  Patients hospitalized in ICUs are 5 to 10 times more likely to acquire nosocomial infections than other hospital patients.
  • 10. Infections that are of great concern to the critical care physician either because of a high mortality rate, diagnostic challenge, frequency of occurrence, contagiousness, or acquisition of antimicrobial resistance are discussed here.
  • 11. ◦ Sepsis ◦ Community-acquired pneumonia ◦ Urosepsis ◦ Infective endocarditis ◦ Necrotizing soft tissue infections ◦ Intra-abdominal infections
  • 12.  Nosocomial pneumonia  Urinary catheter–associated infections  Intravenous catheter–associated infections  Clostridium difficile–associated diarrhea  Haematogenously disseminated candidiasis  Infections in special hosts  Antimicrobial resistance in the ICU  Botulism  Tetanus
  • 13. Wide spectrum of clinical findings ranging from fever, hypothermia, tachycardia, and tachypnea to profound shock and multiple-organ-system failure.  Severe or complicated sepsis: lactic acidosis, acute respiratory distress syndrome (ARDS), acute renal failure, disseminated intravascular coagulation (DIC), shock, CNS dysfunction, or hepatobiliary disease.  May present with altered mental status, unexplained hyperventilation, or tachycardia alone.  Often an identifiable site of infection.  Predisposing risk factors for infection: organ system failure, bed rest, invasive procedures, any antibiotic use, immunocompromised state.
  • 14. Patients present with cough, fever, and occasionally pleuritic chest pain.  Chest x-ray shows pulmonary infiltrates.  Most common cause of community-acquired pneumonia is Streptococcus pneumoniae.
  • 15. The patient may be asymptomatic.  Flank or abdominal pain.  Pyuria and white blood cell casts.  Positive urine culture.
  • 16. Clinical presentation varies depending on infecting organism.  Patients with S. aureus infective endocarditis typically present with a short prodrome and a sepsis syndrome.  Clues to the diagnosis of sub-acute infective endocarditis include a new regurgitant murmur, Roth spots, Osler nodes, Janeway lesions, splinter hemorrhages, hematuria, and splenomegaly.  Blood cultures are needed for diagnosis.
  • 17. Patients complain of pain out of proportion to physical findings.  Essential to differentiate a necrotizing soft tissue infection from a simple cellulitis.  Metabolic acidosis, renal insufficiency, and other signs of organ dysfunction may be present.
  • 18. Symptoms may be nonspecific, with patients reporting vague abdominal pain, anorexia, and fever.  Abdominal examination may reveal absent or diminished bowel sounds, with peritoneal signs.  Laboratory findings are nonspecific in patients with intra-abdominal sepsis.
  • 19. Fever, tachypnea, tachycardia, and abnormal breath sounds.  Risk factors include altered mental status, lung disease, endotracheal tube, or tracheostomy.  Change in volume or appearance of sputum.  Infiltrates or other changes on chest x-ray.  Hypoxemia or worsening arterial blood gases.
  • 20. Although the patient may be asymptomatic, suprapubic tenderness suggests lower tract infection; fever and flank pain suggest upper tract infection.  Pyuria and white blood cell casts.  Positive urine culture.
  • 21. Exit-site infection: erythema, tenderness, induration, and exudate at cutaneous exit site.  Tunnel infection: induration, erythema, tenderness at least 1 cm deep to the skin exit site and without purulent drainage through the exit site.  Catheter sepsis: fever, tachypnea, and tachycardia with positive blood cultures and no other site of infection identified.
  • 22. Watery diarrhea and low-grade fever.  Previous or current treatment with antibiotics—but may occur as long as 6 weeks after antibiotic has been stopped.  Presence of C. difficile toxin in stool.  Sigmoidoscopy may reveal white or yellow plaques of pseudomembranous colitis.
  • 23. Fever despite broad-spectrum antibacterial therapy and negative bacterial blood cultures.  Possible skin manifestations.  Consider in neutropenic hosts and patients with long term vascular access.
  • 24. Many patients have underlying diseases that render them susceptible to specific pathogens. Included among these are  Patients with neutropenia,  Organ transplant recipients,  Diabetics,  Asplenic individuals,  Patients on chronic corticosteroid therapy, and  HIV-infected patients.  Knowledge of an underlying condition may lead a physician to modify or broaden empirical antibiotic therapy when such a patient is admitted to the ICU with infection or suspected infection.
  • 25. The choice of antimicrobial agents to be used in established or strongly suspected bacterial or other infections must be based on an assessment of what organisms are most likely to be involved.  Initial empirical therapy should be dictated, when possible, by results of Gram-stained smears of properly collected specimens such as sputum, urine, aspirated purulent material, or body fluids (eg, blood, cerebrospinal fluid, peritoneal fluid, synovial fluid, pleural fluid, or pericardial fluid).
  • 26. Specific resistance problems encountered in the ICU include ◦ vancomycin-resistant enterococci, ◦ methicillin-resistant S. aureus, ◦ glycopeptideinsensitiveS. aureus, ◦ gram-negative bacilli with extendedspectrumβ- lactamases, ◦ gram-negative bacilli that produce group 1 β- lactamases, and ◦ Acinetobacter baumanii.
  • 27. The evaluation of new fever in the ICU setting involves consideration of diagnoses much different from those encountered in patients in a community setting.  Many noninfectious causes of fever must be considered and excluded in order to avoid missing important diagnoses and perhaps administering antimicrobial agents unnecessarily.
  • 28. Nausea, vomiting, dysphagia, diplopia, dilated and fixed pupils.  Sudden weakness in a previously healthy person.  Cranial nerves affected first (except I and II), followed by descending symmetric paralysis or weakness.  Autonomic nervous system involvement: paralytic ileus, gastric dilation, urinary retention, and orthostatic hypotension.  Absence of sensory or mental status changes.  Botulism toxin isolated from serum, stool, or other body fluids.
  • 29. Generalized weakness or stiffness, with trismus (“lockjaw”) and severe generalized spasms.  Opisthotonos and abdominal rigidity.  Respiratory failure, tachycardia, hypertension, fever, and diaphoresis may be present.
  • 30. There should be monitoring of the infection pattern and the bacteria monitored in order to take the necessary steps to treat infection, prevent resistance development and preventing hospital acquired cross infection.  Essential components of an infection-control program in the critical care environment are the structural design of the critical care unit and the surveillance, prevention, and control of infection functions.
  • 31. Management strategies include employee infection control and education.  Knowledge and education are the most important management tools in the control of infection in the critical care environment.
  • 32. There are eight infection control indicators in hospitals in critical care setting.  The indicator set focuses on:  surgical wound infections,  postoperative pneumonia,  use of urinary catheterization,  ventilator-associated pneumonia,  primary bloodstream infection,  endometritis,  adequacy of surveillance, and  employee measles immunization.
  • 33. Critical care unit staff members may be involved in using indicator rates.  Following the trend rates should suggest organizational systems and processes of care in critical care settings that may warrant further examination and improvement.